Bares Capital Management’s iRadimed IRMD Stock Holding History

Bares Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-283,600	Closed	-$12.5M	–	25
2024 Q2	$12.5M	Buy	283,600 +4,600	+2%	+$196K	0.6%	22
2024 Q1	$12.3M	Buy	279,000 +2,000	+0.7%	+$88.4K	0.49%	26
2023 Q4	$13.1M	Hold	277,000	–	–	0.52%	27
2023 Q3	$12.3M	Hold	277,000	–	–	0.53%	27
2023 Q2	$13.2M	Sell	277,000 -40,000	-13%	-$1.8M	0.46%	28
2023 Q1	$12.5M	Buy	317,000 +45,700	+17%	+$1.66M	0.44%	29
2022 Q4	$7.68M	Buy	271,300 +47,298	+21%	+$1.35M	0.29%	32
2022 Q3	$6.73M	Buy	224,002 +94,762	+73%	+$3.3M	0.26%	34
2022 Q2	$4.39M	Buy	129,240 +67,454	+109%	+$2.42M	0.16%	33
2022 Q1	$2.77M	Hold	61,786	–	–	0.06%	37
2021 Q4	$2.85M	Hold	61,786	–	–	0.06%	35
2021 Q3	$2.08M	Buy	+61,786	New	+$2.1M	0.04%	35

Other funds holding IRMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bares Capital Management's IRMD Position: Q3 2024 in Review

Bares Capital Management sold out of iRadimed (IRMD) in Q3 2024, closing a stake of 283,600 shares — an estimated $12.5M sold.

Bares Capital Management first reported a position in IRMD in Q3 2021 and held it in 12 quarters. The position peaked at $13.2M in Q2 2023. 144 funds tracked by Wall St. Rank hold IRMD as of Q3 2024.

Bares Capital Management reported no remaining iRadimed position as of Q3 2024 after selling out during the quarter.
Bares Capital Management sold 283,600 iRadimed shares in Q3 2024, an estimated $12.5M.
Bares Capital Management first reported a position in iRadimed in Q3 2021 and held it in 12 quarters.
Bares Capital Management's iRadimed position peaked at $13.2M in Q2 2023.
144 funds tracked by Wall St. Rank held iRadimed as of Q3 2024.

Based on Bares Capital Management's 13F filing for Q3 2024, filed 18 Nov 2024.